Down-regulation of transforming growth factor-β type II receptor (TGF-βRII) protein and mRNA expression in cervical cancer

Molecular Cancer

Volumn 7, Issue , 2008, Pages

  Diaz Chavez, Jose ^a   Hernandez Pando, Rogelio ^b   Lambert, Paul F ^c   Gariglio, Patricio ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 14; ESTRADIOL; MESSENGER RNA; MYC PROTEIN; PROTEIN E7; PROTEIN P15; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; CDKN2B PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 2B; MYC PROTEIN, MOUSE; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOHISTOCHEMISTRY; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOPHYSIOLOGY; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SQUAMOUS EPITHELIUM; STRAIN DIFFERENCE; TRANSGENIC MOUSE; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM; VAGINA EPITHELIUM; ANIMAL; BIOSYNTHESIS; FEMALE; GENETICS; HUMAN; METABOLISM; ONCOGENE; PATHOLOGY; UTERINE CERVIX TUMOR; VIROLOGY;

HUMAN PAPILLOMAVIRUS; MUS; MUS MUSCULUS; PAPILLOMAVIRIDAE;

ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; ONCOGENE PROTEINS, VIRAL; ONCOGENES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA2; UTERINE CERVICAL NEOPLASMS;

EID: 39549099328     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-7-3     Document Type: Article

References (51)

1. Lee DK Kim BC Kim IY Cho EA Satterwhite DJ Kim SJ The human papilloma virus E7 oncoprotein inhibits transforming growth factor-beta signaling by blocking binding of the Smad complex to its target sequence J Biol Chem 2002, 277(41):38557-38564. 10.1074/jbc.M206786200 12145312
2. zur Hausen H Papillomavirus infections - a major cause of human cancers Biochim Biophys Acta 1996, 1288(2):F55-78. 8876633
3. zur Hausen H Papillomaviruses and cancer: From basic studies to clinical application Nat Rev Cancer 2002, 2(5):342-350. 10.1038/nrc798 12044010
4. zur Hausen H Are human papillomavirus infections not necessary or sufficient causal factors for invasive cancer of the cervix? Int J Cancer 1995, 63(2):315-316. 10.1002/ijc.2910630228 7591223
5. Harris TG Kulasingam SL Kiviat NB Mao C Agoff SN Feng Q Koutsky LA Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia Am J Epidemiol 2004, 159(9):834-842. 10.1093/aje/kwh115 15105176
6. Brake T Lambert PF Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model Proc Natl Acad Sci U S A 2005, 102(7):2490-2495. 548999 15699322 10.1073/pnas.0409883102
7. Kang SH Won K Chung HW Jong HS Song YS Kim SJ Bang YJ Kim NK Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: Loss of growth sensitivity but conserved transcriptional response to TGF-beta Int J Cancer 1998, 77(4):620-625. 10.1002/(SICI)1097-0215(19980812)77:4<620::AID-IJC23>3.0.CO;2-8 9679767
8. Kim JW Kim HS Kim IK Kim MR Cho EY Kim HK Lee JM Namkoong SE Transforming growth factor-beta 1 induces apoptosis through down-regulation of c-myc gene and overexpression of p27Kip1 protein in cervical carcinoma Gynecol Oncol 1998, 69(3):230-236. 10.1006/ gyno.1998.5003 9648593
9. Shi Y Massague J Mechanisms of TGF-beta signaling from cell membrane to the nucleus Cell 2003, 113(6):685-700. 10.1016/S0092-8674(03)00432-X 12809600
10. Massague J TGF-beta signal transduction Annu Rev Biochem 1998, 67:753-791. 10.1146/annurev.biochem.67.1.753 9759503
11. Pasche B Role of transforming growth factor beta in cancer J Cell Physiol 2001, 186(2):153-168. 10.1002/ 1097-4652(200002)186:2<153::AID-JCP1016>3.0.CO;2-J 11169452
12. Nees M Geoghegan JM Munson P Prabhu V Liu Y Androphy E Woodworth CD Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes Cancer Res 2000. 60(15):4289-4298. 10945644
13. Pei XF Sherman L Sun YH Schlegel R HPV-16 E7 protein bypasses keratinocyte growth inhibition by serum and calcium Carcinogenesis 1998, 19(8):1481-1486. 10.1093/carcin/19.8.1481 9744546
14. Sherman L Schlegel R Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16 J Virol 1996, 70(5):3269-3279. 190193 8627810
15. Creek KE Geslani G Batova A Pirisi L Progressive loss of sensitivity to growth control by retinoic acid and transforming growth factor-beta at late stages of human papillomavirus type 16-initiated transformation of human keratinocytes Adv Exp Med Biol 1995, 375:117-135. 7645423
16. Massague J Chen YG Controlling TGF-beta signaling Genes Dev 2000, 14(6):627-644. 10733523
17. Feng XH Lin X Derynck R Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta Embo J 2000, 19(19):5178-5193. 302105 11013220 10.1093/emboj/19.19.5178
18. Chen CR Kang Y Siegel PM Massague J E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression Cell 2002, 110(1):19-32. 10.1016/S0092-8674(02)00801-2 12150994
19. Pardali K Kowanetz M Heldin CH Moustakas A Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1) J Cell Physiol 2005, 204(1):260-272. 10.1002/jcp.20304 15690394
20. Iavarone A Massague J E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest Mol Cell Biol 1999, 19(1):916-922. 83949 9858615
21. Seijo ER Song H Lynch MA Jennings R Qong X Lazaridis E Muro-Cacho C Weghorst CM Munoz-Antonia T Identification of genetic alterations in the TGFbeta type II receptor gene promoter Mutat Res 2001. 483(1-2):19-26. 11600128
22. Zhang HT Chen XF Wang MH Wang JC Qi QY Zhang RM Xu WQ Fei QY Wang F Cheng QQ Chen F Zhu CS Tao SH Luo Z Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer Clin Cancer Res 2004, 10(7):2359-2367. 10.1158/1078-0432.CCR-0959-3 15073112
23. Brake T Connor JP Petereit DG Lambert PF Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: Identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer Cancer Res 2003, 63(23):8173-8180. 14678972
24. Riley RR Duensing S Brake T Munger K Lambert PF Arbeit JM Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis Cancer Res 2003, 63(16):4862-4871. 12941807
25. Duensing S Duensing A Flores ER Do A Lambert PF Munger K Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes J Virol 2001, 75(16):7712-7716. 115006 11462043 10.1128/JVI.75.16.7712-7716.2001
26. Baldwin RL Tran H Karlan BY Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling Cancer Res 2003, 63(6):1413-1419. 12649207
27. Warner BJ Blain SW Seoane J Massague J Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway Mol Cell Biol 1999, 19(9):5913-5922. 84444 10454538
28. Kang SH Bang YJ Im YH Yang HK Lee DA Lee HY Lee HS Kim NK Kim SJ Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer Oncogene 1999, 18(51):7280-7286. 10.1038/sj.onc.1203146 10602482
29. Markowitz SD Roberts AB Tumor suppressor activity of the TGF-beta pathway in human cancers Cytokine Growth Factor Rev 1996, 7(1):93-102. 10.1016/1359-6101(96)00001-9 8864357
30. Sun L Wu G Willson JK Zborowska E Yang J Rajkarunanayake I Wang J Gentry LE Wang XF Brattain MG Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells J Biol Chem 1994, 269(42):26449-26455. 7929366
31. Alleva DG Burger CJ Elgert KD Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2 J Immunol 1994, 153(4):1674-1686. 8046239
32. Hazelbag S Kenter GG Gorter A Dreef EJ Koopman LA Violette SM Weinreb PH Fleuren GJ Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival J Pathol 2007, 212(3):316-324. 10.1002/path.2168 17503414
33. Welch DR Fabra A Nakajima M Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential Proc Natl Acad Sci U S A 1990, 87(19):7678-7682. 54811 2217201 10.1073/ pnas.87.19.7678
34. Gold LI Jussila T Fusenig NE Stenback F TGF-beta isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis J Pathol 2000 190, 5:579-588. 10.1002/ (SICI)1096-9896(200004)190:5<579::AID-PATH548>3.0.CO;2-I 10727984
35. Oft M Peli J Rudaz C Schwarz H Beug H Reichmann E TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells Genes Dev 1996, 10(19):2462-2477. 10.1101/ gad.10.19.2462 8843198
36. Yi JY Hur KC Lee E Jin YJ Arteaga CL Son YS TGFbeta1 -mediated epithelial to mesenchymal transition is accompanied by invasion in the SiHa cell line Eur J Cell Biol 2002, 81(8):457-468. 10.1078/ 0171-9335-00265 12234017
37. Baritaki S Sifakis S Huerta-Yepez S Neonakis IK Soufla G Bonavida B Spandidos DA Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: Implication of YY1 in cervical tumorigenesis and HPV infection Int J Oncol 2007, 31(1):69-79. 17549406
38. Soufla G Sifakis S Baritaki S Zafiropoulos A Koumantakis E Spandidos DA VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix Cancer Lett 2005, 221(1):105-118. 10.1016/j.canlet.2004.08.021 15797633
39. Tervahauta A Syrjanen S Yliskoski M Gold LI Syrjanen K Expression of transforming growth factor-beta 1 and -beta 2 in human papillomavirus (HPV)-associated lesions of the uterine cervix Gynecol Oncol 1994, 54(3):349-356. 10.1006/gyno.1994.1222 8088612
40. Peralta-Zaragoza O Bermudez-Morales V Gutierrez-Xicotencatl L Alcocer-Gonzalez J Recillas-Targa F Madrid-Marina V E6 and E7 oncoproteins from human papillomavirus type 16 induce activation of human transforming growth factor beta1 promoter throughout Sp1 recognition sequence Viral Immunol 2006, 19(3):468-480. 10.1089/ vim.2006.19.468 16987065
41. Thomas DA Massague J TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance Cancer Cell 2005, 8(5):369-380. 10.1016/j.ccr.2005.10.012 16286245
42. El-Sherif AM Seth R Tighe PJ Jenkins D Decreased synthesis and expression of TGF-beta1, beta2, and beta3 in epithelium of HPV 16-positive cervical precancer: A study by microdissection, quantitative RT-PCR, and immunocytochemistry J Pathol 2000, 192(4):494-501. 10.1002/ 1096-9896(200012)192:4<494::AID-PATH760>3.0.CO;2-W 11113867
43. Comerci JT Jr. Runowicz CD Flanders KC De Victoria C Fields AL Kadish AS Goldberg GL Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix Cancer 1996, 77(6):1107-1114. 10.1002/ (SICI)1097-0142(19960315)77:6<1107::AID-CNCR16>3.0.CO;2-5 8635131
44. Torng PL Chan WY Lin CT Huang SC Decreased expression of human papillomavirus E2 protein and transforming growth factor-beta1 in human cervical neoplasia as an early marker in carcinogenesis J Surg Oncol 2003, 84(1):17-23. 10.1002/jso.10273 12949986
45. Moreno V Bosch FX Munoz N Meijer CJ Shah KV Walboomers JM Herrero R Franceschi S Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC multicentric case-control study Lancet 2002, 359(9312):1085-1092. 10.1016/ S0140-6736(02)08150-3 11943255
46. Liehr JG Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 2000, 21(1):40-54. 10.1210/er.21.1.40 10696569
47. Herber R Liem A Pitot H Lambert PF Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene J Virol 1996, 70(3):1873-1881. 190015 8627712
48. Sinigalliano CD Kuhn DN Jones RD Guerrero MA In situ reverse transcription to detect the cbbL gene and visualize RuBisCO in chemoautotrophic nitrifying bacteria Lett Appl Microbiol 2001, 32(6):388-393. 10.1046/j.1472-765X.2001.00927.x 11412349
49. Ensembl http://www.ensembl.org
50. Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001, 25(4):402-408. 10.1006/meth.2001.1262 11846609
51. Yalcin A Quantification of thioredoxin mRNA expression in the rat hippocampus by real-time PCR following oxidative stress Acta Biochim Pol 2004, 51(4):1059-1065. 15625578